Shukra Pharmaceuticals Q4 Results

  • BSE: 524632
  • NSE: -
  • ISIN: INE551C01028
  • Sector: Biotechnology & Drugs
BSE
60.641.74 (2.95%)
Volume17.35 K
Updated: Mon 25 Nov, 2024 | 15:29:47
NSE
This stock is not traded on NSE
Today: 57.60
61.79
52-Wk: 21.29
129.90

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Shukra Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 10.882.30-%46.25-%
    Selling/ General/ Admin Expenses Total 1.581.17-%1.21-%
    Depreciation/ Amortization 0.520.46-%0.51-%
    Other Operating Expenses Total 3.240.56-%1.85-%
    Total Operating Expense 6.962.48-%43.10-%
    Operating Income 3.92-0.17-%3.15-%
    Net Income Before Taxes 5.220.05-%3.96-%
    Net Income 3.990.03-%3.98-%
    Diluted Normalized EPS 0.910.01-%5.87-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts